National Health (Chemotherapy Pharmaceuticals Access Program) Special Arrangement 2011 (No. PB 87 of 2011)
© 2026 Zoe. All rights reserved.
Zoe is a legal information platform. Always consult the Federal Register of Legislation for authoritative text.
National Health (Chemotherapy Pharmaceuticals Access Program) Special Arrangement 2011 (No. PB 87 of 2011)
Start here
Turn the raw legal text into a practical explanation grounded in National Health (Chemotherapy Pharmaceuticals Access Program) Special Arrangement 2011 (No. PB 87 of 2011).
Schedule 4 Patient contributions
(sections 35 to 37)
| Listed Drug | Form | Manner of Administration | Brand | Quantity or Number of Units | Approved Ex‑manufacturer Price | Claimed Ex‑manufacturer Price |
|---|---|---|---|---|---|---|
| Bleomycin | Powder for injection containing bleomycin sulfate 15,000 I.U. | Injection | Hospira Pty Ltd | 1 | $40.89 | $77.67 |
Notes to the National Health (Chemotherapy Pharmaceuticals Access Program) Special Arrangement 2011 (PB 87of 2011)
Note 1
Note: The National Health (Chemotherapy Pharmaceuticals Access Program) Special Arrangement 2011 (PB 87 of 2011) in force under subsections 100 (1) and (2) of the National Health Act 1953) as shown in this compilation is amended as indicated in the Tables below.
Note: > Note: Table of Instruments
| Title | Date of FRLI Registration | Date ofcommencement | Application, saving ortransitional provisions |
|---|---|---|---|
| PB 87 of 2011 | 30 Nov 2011 (see F2011L02507) | 1 Dec 2011 | |
| PB 101 of 2011 | 20 Dec 2011 (see F2011L02753) | 1 Jan 2012 | — |
| PB 3 of 2012 | 23 Feb 2012 (see F2012L00378) | 1 Mar 2012 | — |
Note: > Note: Table of Amendments
<table cellspacing="0" cellpadding="0" style="width:416.8pt; margin-left:1.4pt; border-collapse:collapse"><tbody><tr><td colspan="2" style="width:406pt; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p class="TableOfAmendHead" style="margin-right:0pt"><span>ad. = added or inserted</span><span> </span><span>am. = amended</span><span> </span><span>rep. = repealed</span><span> </span><span>rs. = repealed and substituted</span></p></td></tr><tr><td style="width:122.5pt; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p class="TableColHead"><span>Provision affected</span></p></td><td style="width:272.7pt; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p class="TableColHead"><span>How affected</span></p></td></tr><tr><td style="width:122.5pt; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p class="TableOfAmend" style="margin-right:0pt"><span style="font-weight:bold">Schedule 1</span></p></td><td style="width:272.7pt; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p class="TableOfAmend" style="margin-right:0pt"><span></span></p></td></tr><tr><td style="width:122.5pt; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p class="TableOfAmend" style="margin-right:0pt"><span>Schedule 1</span><span style="width:96.81pt; text-indent:0pt; font-family:'Lucida Console', monospace; display:inline-block">.................</span></p></td><td style="width:272.7pt; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p class="TableOfAmend" style="margin-right:0pt"><span>am. PB 101 of 2011; PB 3 of 2012</span></p></td></tr><tr><td style="width:122.5pt; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p class="TableOfAmend" style="margin-right:0pt"><span style="font-weight:bold">Schedule 3</span></p></td><td style="width:272.7pt; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p class="TableOfAmend" style="margin-right:0pt"><span></span></p></td></tr><tr><td style="width:122.5pt; border-bottom:0.75pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p class="TableOfAmend" style="margin-right:0pt; margin-bottom:3pt"><span>Schedule 3</span><span style="width:96.81pt; text-indent:0pt; font-family:'Lucida Console', monospace; display:inline-block">.................</span></p></td><td style="width:272.7pt; border-bottom:0.75pt solid #000000; padding-right:5.4pt; padding-left:5.4pt; vertical-align:top"><p class="TableOfAmend" style="margin-right:0pt; margin-bottom:3pt"><span>am. PB 101 of 2011; PB 3 of 2012</span></p></td></tr></tbody></table>